General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-02-19 | 2024-01 | 0 | N/A | N/A | N/A |
2023-11-06 | 2023-07 | 0 | N/A | N/A | N/A |
2023-08-02 | 2023-04 | 0 | N/A | N/A | N/A |
2023-05-04 | 2023-01 | 0 | N/A | N/A | N/A |
2023-02-13 | 2022-10 | 0 | N/A | N/A | N/A |
2022-09-12 | 2022-07 | 0 | -3.83 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2020-11-25 | H.C. Wainwright | Downgrade | Buy | Neutral |
2020-11-25 | Jefferies | Downgrade | Buy | Hold |
2020-11-25 | H.C. Wainwright | Upgrade | Buy | Buy |
2020-11-25 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2020-11-25 | Barclays | Upgrade | Overweight | |
2020-11-25 | Barclays | Upgrade | Overweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2020-03-12 | APPEL RONI A | Director | 0.00 | Sale |
2019-04-07 | BERLIN KENNETH A | Chief Executive Officer | 4.00K | Stock Award(Grant) |
2018-06-25 | BERMAN RICHARD J | Director | 55.67K | Stock Award(Grant) |
2018-03-28 | BONSTEIN SARA M | Chief Financial Officer | 226.67K | Stock Award(Grant) |
2019-04-10 | GUTIERREZ ANDRES A. | Officer | 3.75K | Stock Award(Grant) |
2019-04-10 | HENDERSON MOLLY | Chief Financial Officer | 5.83K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2021-09-29 | Vanguard Group, Inc. (The) | 5.96M | 3.11M | 4.09% |
2021-09-29 | Blackrock Inc. | 1.26M | 655.66K | 0.86% |
2021-09-29 | Geode Capital Management, LLC | 1.14M | 592.18K | 0.78% |
2021-09-29 | State Street Corporation | 385.06K | 200.81K | 0.26% |
2021-09-29 | Northern Trust Corporation | 252.88K | 131.88K | 0.17% |
2021-09-29 | Millennium Management LLC | 244.97K | 127.75K | 0.17% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2021-09-29 | Vanguard Total Stock Market Index Fund | 4.10M | 2.14M | 2.82% |
2021-09-29 | Vanguard Extended Market Index Fund | 1.66M | 867.68K | 1.14% |
2021-10-30 | Fidelity Extended Market Index Fund | 753.76K | 365.27K | 0.52% |
2021-09-29 | Price (T.Rowe) U.S. Equities Trust | 166.75K | 86.96K | 0.11% |
2021-10-30 | iShares Core S&P Total U.S. Stock Market ETF | 159.79K | 77.43K | 0.11% |
2021-10-30 | Fidelity NASDAQ Composite Index Fund | 132.08K | 64.01K | 0.09% |
Split | Date |
---|---|
1 : 80 | 2022-06-06 |
1 : 15 | 2019-03-29 |
0.008 : 1 | 2013-07-15 |
Bears getting active lol
Guessing low 50s end of day
May kick myself for selling my shares today, but Sometimes you just can’t watch your stock go below your purchase price over and over again. Had to get out w a gain today
Listeria is a spore producing bacteria found in foods. It has been found that you can produce antigens to cure cancer and major phase III ran in ADXS with support of Merck . BO almost eminent. Visit FDA trials site. Do your DD . This is the Tesla of Biopharm.
I still think they drop offering news in upper 40s later. It explains volume and price being kept down n certain range. Up after that ?
Bet there was offering in high 40s
Got out at .53 Broke even. This market sucks.
Hot market for cancer drugs
https://www.reuters.com/article/us-immunomedics-m-a-gilead-sciences-idCAKBN2630ZL
I think BidAss should STFU.
Did I see an offering for $20 million coming?
And... the markets are correcting on a day this thing finally starts moving.
Funny how the companies in this LD conference are getting killed today.